Your browser doesn't support javascript.
loading
Mepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres.
Sanchez-Melendez, Stephanie N; Shaw, Katharina S; Pan, Catherina X; Taylor, Dustin L; Shahriari, Neda; Mazori, Daniel R; Vleugels, Ruth Ann.
Afiliação
  • Sanchez-Melendez SN; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, and Ponce Health Sciences University, School of Medicine, Ponce, Puerto Rico.
  • Shaw KS; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pan CX; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Taylor DL; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Shahriari N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Mazori DR; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA.
  • Vleugels RA; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. rvleugels@bwh.harvard.edu.
Clin Exp Rheumatol ; 41(8): 1721-1722, 2023 08.
Article em En | MEDLINE | ID: mdl-37246772

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antiasmáticos / Eosinofilia Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antiasmáticos / Eosinofilia Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article